
Pharma News
-
Chemical API market is building core competitive advantages
2022-08-19With high R&D investment, Chinese CRO/CDMO companies are able to efficiently undertake outsourced R&D and manufacturing business related to BigPharma and Biotech at home and abroad based on good engineer's bonus
-
Overview Of The Development Of China's Pharmaceutical Industry 2022
2022-08-18In recent years, the scale of China's pharmaceutical market has been growing at a relatively fast pace. Data shows that China's pharmaceutical market size from 1,430.4 billion RMB in 2017 to 179.19 billion RMB in 2020
-
Analysis of the Chinese Veterinary Drug Raw Material Market in the 33rd Week of 2022
2022-08-18At present, the veterinary drug raw material market is stable, and themarket inquiries and negotiations are still mainly concentrated on doxycyclinehydrochloride, florfenicol, penicillin potassium industrial salt
-
The Global API Industry Pattern is Gradually Shifting to China and India
2022-08-17Before the 1990s, Europe and the United States were the most important API production areas in the world, with large-scale industries and advanced technology.
-
FDA Issues Drug Statement, Merck's Hypoglycemic Drug Sitagliptin Detected Potential Carcinogen
2022-08-16Recently, the US Food and Drug Administration (FDA) official website issued a drug statement: The FDA recently found the nitrosamine impurity Nitroso-STG-19 (NTTP) in some samples of the type 2 diabetes drug sitagliptin.
-
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
2022-08-12On August 2, 2022, Hengrui Medicine issuedan announcement that the company received the approval and issuance of the"Drug Clinical Trial Approval Letter" for HRS-4642 injection from theState Food and Drug Administration.
-
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(2)
2022-08-12Sulfonamide products were generally in a low-key and weak state in the first half of this year, which was greatly affected by the market conditions of pig raising. Inquiries and transactions of some products decreased significantly.
-
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(1)
2022-08-12Doxycycline hydrochloride, the market price is 570-590. In July, the price increased by more than 100 yuan, up 26.1% month-on-month.
-
Pfizer's $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue
2022-08-09According to Biohaven's financial report, the double-acting migraine drug rimegepant (trade name: Nurtec) has sales revenue of US$318 million in the first half of this year
-
2022H1: Top 10 Best-Selling Drugs in the World
2022-08-05With the release of the semi-annual reports of major pharmaceuticalcompanies in 2022, the TOP10 list of the world's best-selling drugs has becomeclear.
-
Vitamin Market Analysis
2022-08-02Recently, market inquiries have been weak, and the market has a strong wait-and-see mood. Mainstream factories frequently release news of production shutdowns.
-
Market Analysis of Veterinary Drug Raw Materials
2022-08-02Penicillin Potassium Industrial Salt - The market capacity and supply are relatively concentrated. Mainstream factories have raised their quotations, attracting high attention
-
Huadong Medicine Liraglutide Injection for Obesity or Overweight Indication Application for Listing
2022-08-02On July 12, 2022, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (hereinafter referred to as "Zhongmei Huadong"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd.
-
Upadatinib's launch accelerated: Crohn's disease has simultaneously submitted marketing applications in FDA&EMA
2022-07-29On July 27, AbbVie announced that it had submitted to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for upadacitinib (trade name Rinvoq, 45mg [induction dose] and 15mg and 30 mg [maintenance dose])
-
Progesterone Market Potential is Huge
2022-07-25Progesterone, a steroid hormone synthesized by the placenta, ovaries and adrenal glands, is essential for reproductive function and regulation of the menstrual cycle
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
2022-07-14Sulfonamide products are affected by the breeding market, and the overall price has fallen
-
Market Analysis of Cephalosporins and Penicillins
2022-07-14Ceftiofur sodium, ceftiofur hydrochloride, cephalosporins fell as a whole, the average market transaction price, ceftiofur sodium 1860, down 18.1% year-on-year; ceftiofur hydrochloride 1380, down 20.0% year-on-year
-
AbbVie Ends An Alzheimer's Immunotherapy Collaboration with Alector
2022-07-11AbbVie has decided to terminate a collaboration focused on the development of Alzheimer's disease treatment AL003, Alector disclosed in a filing with the U.S. Securities and Exchange Commission a few days ago.
-
Oseltamivir is Gone, and the Pattern of Anti-influenza Drugs is Reversed!
2022-06-23The latest weekly influenza report of the National Influenza Center on June 17 (6.6-6.12) showed that the proportion of influenza-like cases (ILI%) among outpatient cases reported by sentinel hospitals in southern provinces was 5.8%
-
Market Comparison Before and after the 3rd Batch of Nationally Sourced Hypoglycemic Drug Metformin
2022-06-23As a well-known hypoglycemic drug, metformin plays an important role in the field of diabetes treatment. It is the widest and largest variety in the field of diabetes in terms of its scope of use and scale.
-
Pharmaceutical Industry Overview
The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.Published in: Aug. 2024
Hot News
-
Top 10 Global CDMO Rankings in 2022
-
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody
-
Forecast of TOP 10 global best-selling drugs in 2021
-
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
China State Drug Administration officially approved Semaglutide for type 2 diabetes
-
Top 30 best-selling oncology drugs in the world in 2020
-
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan